Latest News


Encouraging news for those with chronic kidney disease.

Improved accessibility to a treatment for kidney disease has been welcomed by Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock. Forxiga (dapagliflozin), an oral medicine which can help slow the progression of proteinuric chronic kidney disease, has now been listed on the Pharmaceutical Benefits Scheme. The listing aims to help those with the c.....
Read more

Category: Cardiovascular and Renal Research, New Treatment

New Academic Director shares vision for research success.

Ambitious leadership, functional wellbeing and a passion for collaboration An international healthcare destination celebrated for its collaborative spirits and dedication to human health and wellbeing. This is Professor Jim Elliott’s vision for how the collaboration between the Kolling Institute, the Faculty of Medicine and Health and the Northern Sydney Local Health District will evolve.....
Read more

Category: Research Excellence

Researchers develop test to identify the severity of kidney disease.

We may soon have a safer approach to diagnosing and measuring the progression of chronic kidney disease following new research by the team from the Kolling Institute’s Renal Research Laboratory. The condition is a global health issue, which now affects more than 13 per cent of the worldwide population. Chronic kidney disease is a progressive disease that leads to end-stage kidney failur.....
Read more

Category: Cardiovascular and Renal Research, Research Excellence

Link between obesity severity and adverse outcomes for pregnant women and their babies.

There are calls for a greater focus on weight management following new research defining the relationship between obesity and pregnancy-related complications for mother and baby. The study follows an increase in obesity levels globally as well as a rise in prevalence during pregnancy. Today, more than 20 per cent of Australian women have obesity at the time of conception. Kolling Institu.....
Read more

Category: Research Excellence

The Kolling’s up and coming talent recognised .

Acting Executive Director Professor Jim Elliott has announced the winners of the inaugural Kolling Institute Emerging Leader Awards, saying there’s an inspiring depth of expertise throughout the institute. Professor Elliott said the new awards recognise our young leaders across our basic and translational research, and were initiated by the institute’s Workforce and Culture Enabler Commi.....
Read more

Category: Awards

Recognition for a remarkable career.

Kolling Institute researcher and Royal North Shore Hospital clinician Professor Carol Pollock has been recognised for her extraordinary contribution to healthcare in this year’s Queen’s birthday honour roll. Professor Pollock has been appointed an officer of the order of Australia for her distinguished service to medical research, education and science, nephrology, and clinical practice .....
Read more

Category: Awards, Cardiovascular and Renal Research, Research Excellence

Common, easily accessible medication could reduce severe COVID-19 symptoms.

A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, marking a significant breakthrough in the treatment of the virus. An exciting new study, involving researchers from across Australia and India, will investigate whether existing blood pressure medications can reduce the risk of severe disease as well as the duration of severe symptoms. Rese.....
Read more

Category: New Treatment